Moses O. Oyewumi, Ph.D. - Publications

Affiliations: 
2003 University of Kentucky, Lexington, KY 
Area:
Pharmaceutical Chemistry, Public Health, Cell Biology

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Manickavasagam D, Wehrung D, Chamsaz EA, Sanders M, Bouhenni R, Crish SD, Joy A, Oyewumi MO. Assessment of Alkoxylphenacyl-Based Polycarbonates as a Potential Platform for Controlled Delivery of a Model Anti-Glaucoma Drug. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 27320697 DOI: 10.1016/j.ejpb.2016.06.012  0.96
2016 Oyewumi MO, Manickavasagam D, Novak K, Wehrung D, Paulic N, Moussa FM, Sondag GR, Safadi FF. Osteoactivin (GPNMB) ectodomain protein promotes growth and invasive behavior of human lung cancer cells. Oncotarget. PMID 26883195 DOI: 10.18632/oncotarget.7323  0.96
2015 Ohanyan V, Yin L, Bardakjian R, Kolz C, Enrick M, Hakobyan T, Kmetz J, Bratz I, Luli J, Nagane M, Khan N, Hou H, Kuppusamy P, Graham J, Fu FK, ... ... Oyewumi MO, et al. Requisite Role of Kv1.5 Channels in Coronary Metabolic Dilation. Circulation Research. 117: 612-21. PMID 26224794 DOI: 10.1161/CIRCRESAHA.115.306642  0.96
2015 Oyewumi MO, Wehrung D, Sadana P. Gelucire-stabilized nanoparticles as a potential DNA delivery system. Pharmaceutical Development and Technology. 1-8. PMID 25915179 DOI: 10.3109/10837450.2015.1041043  0.96
2014 Oyewumi MO, Alazizi A, Wehrung D, Manochakian R, Safadi FF. Emerging lung cancer therapeutic targets based on the pathogenesis of bone metastases. International Journal of Cell Biology. 2014: 236246. PMID 25197279 DOI: 10.1155/2014/236246  0.96
2014 Oyewumi MO, Alazizi A, Liva S, Lin L, Geldenhuys WJ. Screening and identification of novel compounds with potential anti-proliferative effects on gallium-resistant lung cancer through an AXL kinase pathway. Bioorganic & Medicinal Chemistry Letters. 24: 4553-6. PMID 25131538 DOI: 10.1016/j.bmcl.2014.07.072  0.96
2014 Wehrung D, Chamsaz EA, Joy A, Oyewumi MO. Formulation and photoirradiation parameters that influenced photoresponsive drug delivery using alkoxylphenacyl-based polycarbonates. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 88: 962-72. PMID 25127989 DOI: 10.1016/j.ejpb.2014.07.011  0.96
2013 Bi L, Wehrung D, Oyewumi MO. Contributory roles of innate properties of cetyl alcohol/gelucire nanoparticles to antioxidant and anti-inflammation activities of quercetin. Drug Delivery and Translational Research. 3: 318-29. PMID 25788280 DOI: 10.1007/s13346-013-0130-6  0.96
2013 Wehrung D, Bi L, Geldenhuys WJ, Oyewumi MO. Antitumor efficacy and tolerability of systemically administered gallium acetylacetonate-loaded gelucire-stabilized nanoparticles. Journal of Biomedical Nanotechnology. 9: 1029-40. PMID 23858967 DOI: 10.1166/jbn.2013.1598  0.96
2013 Wehrung D, Sun S, Chamsaz EA, Joy A, Oyewumi MO. Biocompatibility and in vivo tolerability of a new class of photoresponsive alkoxylphenacyl-based polycarbonates. Journal of Pharmaceutical Sciences. 102: 1650-60. PMID 23529816 DOI: 10.1002/jps.23510  0.96
2013 Maddipatla MVSN, Wehrung D, Tang C, Fan W, Oyewumi MO, Miyoshi T, Joy A. Photoresponsive coumarin polyesters that exhibit cross-linking and chain scission properties Macromolecules. 46: 5133-5140. DOI: 10.1021/ma400584y  0.96
2012 Wehrung D, Geldenhuys WJ, Bi L, Oyewumi MO. Biocompatibility, efficacy and biodistribution of Gelucire-stabilized nanoparticles engineered for docetaxel delivery. Journal of Nanoscience and Nanotechnology. 12: 2901-11. PMID 22755140 DOI: 10.1166/jnn.2012.5789  0.96
2012 Wehrung D, Oyewumi MO. Antitumor effect of novel gallium compounds and efficacy of nanoparticle-mediated gallium delivery in lung cancer. Journal of Biomedical Nanotechnology. 8: 161-71. PMID 22515104 DOI: 10.1166/jbn.2012.1361  0.96
2012 Wehrung D, Geldenhuys WJ, Oyewumi MO. Effects of gelucire content on stability, macrophage interaction and blood circulation of nanoparticles engineered from nanoemulsions. Colloids and Surfaces. B, Biointerfaces. 94: 259-65. PMID 22386863 DOI: 10.1016/j.colsurfb.2012.02.005  0.96
2010 Oyewumi MO, Kumar A, Cui Z. Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses. Expert Review of Vaccines. 9: 1095-107. PMID 20822351 DOI: 10.1586/erv.10.89  0.96
2004 Oyewumi MO, Yokel RA, Jay M, Coakley T, Mumper RJ. Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice. Journal of Controlled Release : Official Journal of the Controlled Release Society. 95: 613-26. PMID 15023471 DOI: 10.1016/j.jconrel.2004.01.002  0.96
2003 Lockman PR, Oyewumi MO, Koziara JM, Roder KE, Mumper RJ, Allen DD. Brain uptake of thiamine-coated nanoparticles. Journal of Controlled Release : Official Journal of the Controlled Release Society. 93: 271-82. PMID 14644577 DOI: 10.1016/j.jconrel.2003.08.006  0.96
2003 Oyewumi MO, Liu S, Moscow JA, Mumper RJ. Specific association of thiamine-coated gadolinium nanoparticles with human breast cancer cells expressing thiamine transporters. Bioconjugate Chemistry. 14: 404-11. PMID 12643751 DOI: 10.1021/bc0340013  0.96
2003 Oyewumi MO, Mumper RJ. Influence of formulation parameters on gadolinium entrapment and tumor cell uptake using folate-coated nanoparticles. International Journal of Pharmaceutics. 251: 85-97. PMID 12527178 DOI: 10.1016/S0378-5173(02)00587-2  0.96
2003 Mumper RJ, Cui Z, Oyewumi MO. Nanotemplate engineering of cell specific nanoparticles Journal of Dispersion Science and Technology. 24: 569-588. DOI: 10.1081/DIS-120021814  0.96
2002 Oyewumi MO, Mumper RJ. Engineering tumor-targeted gadolinium hexanedione nanoparticles for potential application in neutron capture therapy. Bioconjugate Chemistry. 13: 1328-35. PMID 12440870 DOI: 10.1021/bc025560x  0.96
2002 Oyewumi MO, Mumper RJ. Gadolinium-loaded nanoparticles engineered from microemulsion templates. Drug Development and Industrial Pharmacy. 28: 317-28. PMID 12026224 DOI: 10.1081/DDC-120002847  0.96
2001 Lehmler HJ, Oyewumi MO, Jay M, Bummer PM. Behavior of partially fluorinated carboxylic acids at the air-water interface Journal of Fluorine Chemistry. 107: 141-146. DOI: 10.1016/S0022-1139(00)00384-5  0.96
Show low-probability matches.